Detection of myocardial involvement in patients with sarcoidosis applying T2-weighted, contrast-enhanced, and cine magnetic resonance imaging: Initial results of a prospective study

Journal of Computer Assisted Tomography

Volumn 26, Issue 5, 2002, Pages 762-767

  Vignaux, Olivier ^a   Dhote, Robin ^a   Duboc, Denis ^a   Blanche, Philippe ^a   Devaux, Jean Yves ^a   Weber, Simon ^a   Legmann, P ^a  

^a UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

Heart, diseases; Heart, MR; Sarcoidosis

Indexed keywords

ECHOCARDIOGRAPHY; HEART; IMAGE ENHANCEMENT; NUCLEAR MEDICINE; PATIENT REHABILITATION; TUMORS;

CONTRAST-ENHANCED; CONTRAST-ENHANCED IMAGES; CORONARY ANGIOGRAPHY; CORONARY DISEASE; HEART DISEASE; HEART, MR; PROSPECTIVE STUDY; SARCOIDOSIS; T2 WEIGHTED; THALLIUM-201;

MAGNETIC RESONANCE IMAGING;

GADOLINIUM; PENTETIC ACID; THALLIUM;

ADULT; ANGIOCARDIOGRAPHY; ARTICLE; CINEANGIOCARDIOGRAPHY; CLINICAL ARTICLE; CONTRAST ENHANCEMENT; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DISEASE CLASSIFICATION; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAM; FEMALE; HEART DISEASE; HEART MUSCLE; HEART MUSCLE CONTRACTILITY; HUMAN; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PATIENT; PHYSICAL EXAMINATION; PRIORITY JOURNAL; PROSPECTIVE STUDY; SARCOIDOSIS; SCINTIGRAPHY; SYMPTOM; SYMPTOMATOLOGY; THICKNESS; WEIGHT;

EID: 0036761188     PISSN: 03638715     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004728-200209000-00017     Document Type: Article

References (15)

1. Valantine H, McKenna WJ, Nihoyannopoulos P. Sarcoidosis: A pattern of clinical and morphological presentation. Br Heart J 1987;57:256-63.
2. Silverman KJ, Hutchins GM, Bulkley BH. Cardiac sarcoid: A clinicopathological study of 84 unselected patients with systemic sarcoidosis. Circulation 1978;58:1204-11.
3. Abeler V. Sarcoidosis of the cardiac conducting system. Am Heart J 1979;97:701-7.
4. Sharma OP. Cardiac and neurologic dysfunction in sarcoidosis. Clin Chest Med 1997;18:813-25
5. Riedy K, Fisher MR, Belic N, Koenigsberg D. MR imaging of myocardial sarcoidosis. AJR Am J Roentgenol 1988;151:915-6.
6. Dupuis JM, Victor J, Furber A, Pezard P, Lejeune LL, Tadei A. Value of magnetic resonance imaging in sarcoidosis. A propos of a case. Archiv Malad Cœur Vaisseaux 1994;87:105-10.
7. Chandra M, Silverman ME, Oshinski J, Pettigrew R. Diagnosis of cardiac sarcoidosis aided by MRI. Chest 1996;110:562-5.
8. Doherty MJ, Kumar SK, Nicholson AA, McGivern DV. Cardiac sarcoidosis: The value of magnetic resonance imaging in diagnosis and assessment of response to treatment. Respir Med 1998;92: 697-9.
9. Matsuki M, Matsuo M. MR findings of myocardial sarcoidosis. Clin Radiol 2000;55:323-5.
10. Inoue S, Shimada T, Murakami Y. Clinical significance of gadolinium-DTPA-enhanced MRI for detection of myocardial lesions in a patient with sarcoidosis. Clin Radiol 1999;54:70-2.
11. Schulz-Menger J, Strohm O, Dietz R, Friedrich MG. Visualisation of cardiac involvement in patients with systemic sarcoidosis applying contrast-enhanced magnetic resonance imaging. MAGMA 2000;11:82-3.
12. Shimata T, Shimada K, Sakane T, et al. Diagnosis of cardiac sarcoidosis and evaluation of the effects of steroid therapy by gadolinium-DTPA-enhanced magnetic resonance imaging. Am J Med 2001;110:520-7.
13. Vignaux O, Augui J, Coste J, et al. Comparison of optimized single-shot fast spin-echo with conventional spin-echo sequences for MR imaging of the heart - Initial experience. Radiology 2001; 219:545-50.
14. Aso H, Takeda K, Ito T, Shiraishi T, Matsumura K, Nakagawa T. Assessment of myocardial fibrosis in cardiomyopathic hamsters with gadolinium-DTPA enhanced magnetic resonance imaging. Invest Radiol 1998;33:22-32.
15. Vignaux O, Dhote R, Duboc D, Blanche P, Dusser D, Weber S, Legmann P. Clinical significance of myocardial magnetic resonance abnormalities in patients with sarcoidosis: a one-year follow-up study. Chest 2002 (in press).